Patents by Inventor Stevens Kastrup Rehen

Stevens Kastrup Rehen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11987808
    Abstract: The present invention relates to the field of stem cell biology, in particular the linage specific differentiation of pluripotent or multipotent stem cells. Specifically described are methods to direct the lineage specific differentiation of hiPSC to sensitive neurons or neuronal fibers innervating the human skin, such as neural crest stem cells (NCPCs) and here called peripheral sensory neurons (PSNs) using novel culture conditions. It is also described a method for screening a biological agent in vitro. The PSNs obtained using the methods of the present invention are further contemplated for various uses including, but limited to, use in in vitro tests or disease modelling, such as drug discovery assays, cell therapy on a higher scale, detecting a range of skin irritants and other compounds of interest, for studying skin aging mechanism, and for producing a dermocosmetic product.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: May 21, 2024
    Assignee: L'OREAL
    Inventors: Rodrigo De Vecchi, Stevens Kastrup Rehen, Marilia Zaluar, Lionel Breton
  • Publication number: 20200216803
    Abstract: The present invention relates to the field of stem cell biology, in particular the linage specific differentiation of pluripotent or multipotent stem cells. Specifically described are methods to direct the lineage specific differentiation of hiPSC to sensitive neurons or neuronal fibers innervating the human skin, such as neural crest stem cells (NCPCs) and here called peripheral sensory neurons (PSNs) using novel culture conditions. It is also described a method for screening a biological agent in vitro. The PSNs obtained using the methods of the present invention are further contemplated for various uses including, but limited to, use in in vitro tests or disease modelling, such as drug discovery assays, cell therapy on a higher scale, detecting a range of skin irritants and other compounds of interest, for studying skin aging mechanism, and for producing a dermocosmetic product.
    Type: Application
    Filed: June 20, 2017
    Publication date: July 9, 2020
    Inventors: Rodrigo DE VECCHI, Stevens Kastrup REHEN, Marilia ZALUAR, Lionel BRETON
  • Patent number: 9725695
    Abstract: The invention provides a defined low protein culture medium for maintaining cells in an undifferentiated state, the medium comprising: a basal medium, an organic acid from the tricarboxylic acid cycle, nonessential amino acids, a combination of growth factors selected from the group consisting of FGF-2 protein, an IGF-1 protein or insulin, a Transferrin protein, and a TGF beta 1 protein, wherein the medium is essentially feeder-free, essentially xeno-free, essentially free of beta-mercaptoethanol, and essentially free of animal-derived or human-derived proteins.
    Type: Grant
    Filed: May 5, 2011
    Date of Patent: August 8, 2017
    Assignees: The Regents of the University of California, Universidade Federal Do Rio De Janeiro
    Inventors: Alysson Muotri, Paulo Andre Nobrega Marinho, Stevens Kastrup Rehen, Leda Dos Reis Castilho
  • Publication number: 20130059377
    Abstract: The invention provides a defined low protein culture medium for maintaining cells in an undifferentiated state, the medium comprising: a basal medium, an organic acid from the tricarboxylic acid cycle, nonessential amino acids, a combination of growth factors selected from the group consisting of FGF-2 protein, an IGF-1 protein or insulin, a Transferrin protein, and a TGF beta 1 protein, wherein the medium is essentially feeder-free, essentially xeno-free, essentially free of beta-mercaptoethanol, and essentially free of animal-derived or human-derived proteins.
    Type: Application
    Filed: May 5, 2011
    Publication date: March 7, 2013
    Inventors: Alysson Muotri, Paulo Andre Nobrega Marinho, Stevens Kastrup Rehen, Leda Dos Reis Castilho
  • Publication number: 20090305244
    Abstract: The distribution of cell karyotypes within a population of cells can determine the phenotype and ability of stem cells to differentiate into desired cell types, to function normally, as well as represent risk for adverse events like cancer. Therefore, determination of the aneuploid mosaic status of a cell population is useful in identifying and/or maintaining desirable traits and eliminating undesirable traits in stem cells, and for defining them at the level of their chromosomal complement.
    Type: Application
    Filed: November 9, 2006
    Publication date: December 10, 2009
    Applicant: The Scripps Research Institute
    Inventors: Suzanne Earlene Peterson, Yun Chun Yung, Stevens Kastrup Rehen, Jurjen Willem Westra, Jerold Jun Chun